Top Stories
-
Brain, exercise, fall risk, fatigue, frailty, multiple sclerosis, Neurodegenerative Diseases, pilot randomized trial, Psychiatry, Psychology, quality of life, rehabilitation, resistance training, therapy, treadmill training, Virtual realityMultiple Sclerosis Frailty Exercise Improved Fatigue in 6 Weeks
-
BMC Psychiatry, community settings, Denmark, Editor Simon Bradstreet, group delivered support programme, group support, Mental health, peer support, peer support intervention, randomised controlled trial, recovery, recovery approach, topicalGroup peer support boosts recovery in Danish community trial
Recent Posts
-
agitation, antipsychotics, atypical antipsychotics, cardiovascular disease, CPRD, Dementia, Drugs, FDA black-box warning, matched cohort study, Neurodegenerative Diseases, older adults, Psychiatry, risperidone, side effects, strokeRisperidone Stroke Risk in Dementia: HR 1.28 Across CVD Subgroups
The risperidone-stroke link in dementia is one of the longest-running safety signals…
-
anticoagulants, antidepressants, Anxiety, atrial fibrillation, bleeding, case-crossover, cohort study, depression, DOACs, drug interactions, Drugs, gastrointestinal bleeding, Interactions, intracranial hemorrhage, ssrisSSRIs + DOACs: No Excess Bleeding vs. Other Antidepressants
SSRIs raise bleeding risk on their own. DOACs (direct oral anticoagulants —…
-
bipolar disorder, cardiac malformations, cohort study, Drugs, Ebstein anomaly, lithium, mood stabilizers, NICE guidelines, perinatal, postpartum psychosis, postpartum relapse, pregnancy, PsychiatryLithium in Pregnancy: Why Late Discontinuation Backfires
Lithium prescribing during pregnancy sits in a knot of competing risks. The…
-
Autism, Danish registers, familial confounding, genetics, indirect genetic effects, iPSYCH, maternal health, Mendelian randomization, pregnancy, Psychiatry, sibling comparison, ssris, valproateMaternal Health and Autism Risk: Most Links Are Genetic, Not Prenatal
For two decades, headlines have linked autism to maternal obesity, depression, anxiety,…
-
abuse liability, addiction, case report, depression, Drugs, esketamine, ketamine, ketamine cystitis, nmda antagonist, Psychiatry, R-ketamine, S-ketamine, Spravato, suicidality, suicide, treatment-resistant depressionKetamine Addiction After One Therapeutic Dose: How Rare Is It?
Research Highlights One published case is not a base rate. Roelandt and…
-
Prevention Efforts Increasingly See Suicide Through a Broader Lens
If you or someone you know may be experiencing a mental health…
-
adverse events, antidepressants, British Journal of Psychiatry, clinical trial, depression, difficult-to-treat depression, Editor Eimear Foley, feasibility, major depressive disorder, mdma, MDMA-assisted psychotherapy, open label study, placebo, proof-of-principle, psychedelics, psychotherapy, randomised controlled trial, remission, Safety, Suicidal Ideation, tolerability, topicalMDMA-assisted therapy for depression: a promising but early first step
MDMA was first made in 1912 as an accidental byproduct of a…
-
accelerated aging, advanced aging, aging, antipsychotics, brain age, Dementia, epigenetic clock, mortality, neuroscience, psychosis, schizophrenia, systematic review, telomere lengthSchizophrenia and Accelerated Aging: What The Latest Research Suggests In 2026
Research Highlights People with schizophrenia die 15–20 years earlier on average (SMR…
-
exenatide, GLP-1, lixisenatide, network meta-analysis, Neurodegenerative Diseases, neurology, neuroprotection, neuroscience, Ozempic, parkinson’s diseaseCan GLP-1 Drugs Slow Parkinson’s Disease? Evidence from 5 Trials
Research Highlights GLP-1 receptor agonists are diabetes drugs (Ozempic, Trulicity, Byetta) being…
-
anti-ribosomal P, antiphospholipid antibodies, autoimmune, complement, first episode psychosis, lupus, neuropsychiatric lupus, NPSLE, Psychiatry, psychosis, schizophrenia, SLELupus Psychosis: 4.5% Prevalence and Antibody Predictors
Research Highlights Across 65 studies and 31,495 lupus patients, 4.5% develop psychosis…
